| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |